The following individuals are eligible to receive a two-dose primary series of Imvamune® for PrEP:Ī) Two-spirit, non-binary, transgender cisgender, intersex, or gender-queer individuals who self-identify or have sexual partners who self-identify as belonging to the gay, bisexual, pansexual and other men who have sex with men (gbMSM) community AND at least one of the following:
In alignment with the recently updated Ministry of Health Monkeypox Vaccine (Imvamune®) Guidance for Health Care Providers, Imvamune® vaccine should be offered as a two-dose primary series, with at least 28 days between the first and second dose, for individuals currently eligible for pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
0 kommentar(er)
